Trial Profile
Efficacy of long-acting risperidone injection at 2 dose levels in schizophrenic and schizoaffective patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen
- 05 Nov 2010 New trial record.